Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies - ACR Meeting Abstracts

Por um escritor misterioso
Last updated 13 maio 2024
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Background/Purpose: Although the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is used to assess the activity of axial disease in patients (pts) with PsA, only one of its questions is specific to axial symptoms. Alternatively, the Ankylosing Spondylitis Disease Activity Score (ASDAS) excludes assessment of enthesitis, gives less weight to peripheral activity and is considered […]
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Plenary Presentations - 2021 - International Journal of Rheumatic Diseases - Wiley Online Library
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Treating to Target(s) With Interleukin-17 Inhibitors - Charles W. Lynde, Jennifer Beecker, Jan Dutz, Cathy Flanagan, Lyn C. Guenther, Wayne Gulliver, Kim Papp, Proton Rahman, Dalton Sholter, Gordon E. Searles, 2019
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Soumya CHAKRAVARTY, Senior Director & Strategic Lead Rheumatology Therapeutic Area, MD PhD, Immunology Medical Affairs
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Treat to Target in Spondyloarthritis: Myth or Reality? - European Medical Journal
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Efficacy of Guselkumab Across BASDAI Components in Treating Axial-Related Symptoms of Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-controlled Studies - ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of 11 Phase 2/3 Clinical Studies in Psoriasis and Psoriatic Arthritis - ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Efficacy of Guselkumab in Three Cohorts of Biologic-Naïve PsA Patients with Axial Involvement Defined Based on Imaging and Machine-Learning Criteria: Pooled Analysis of Two Phase 3 Studies - ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
PDF) Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
PDF) Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Poster Abstract Presentation Abstracts - 2023 - International Journal of Rheumatic Diseases - Wiley Online Library
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
PDF) Axial involvement in psoriatic arthritis: An update for rheumatologists

© 2014-2024 praharacademy.in. All rights reserved.